Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China flag China · Delayed Price · Currency is CNY
26.64
+0.03 (0.11%)
Nov 18, 2026, 2:55 PM CST

Yifeng Pharmacy Chain Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Yifeng Pharmacy Chain stock has a consensus rating of "Buy" and an average price target of ¥32.28. The average 1-year stock price forecast is 21.17% higher than the current stock price, while the lowest is ¥22.60 (-15.17%) and the highest is ¥43.28 (+62.46%).

Price Target: ¥32.28 (+21.17%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥22.60¥32.28¥32.80¥43.28
Change-15.17%+21.17%+23.12%+62.46%

Analyst Ratings

The average analyst rating for Yifeng Pharmacy Chain stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy888899
Buy555555
Hold111211
Sell111111
Strong Sell000000
Total151515161616

Financial Forecast

Revenue This Year
26.08B
from 24.43B
Increased by 6.73%
Revenue Next Year
28.41B
from 26.08B
Increased by 8.94%
EPS This Year
1.59
from 1.33
Increased by 19.70%
EPS Next Year
1.85
from 1.59
Increased by 16.40%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
15.33B19.89B22.59B24.06B24.43B26.08B
Revenue Growth
16.60%29.75%13.59%6.53%1.54%6.73%
Gross Profit
6.14B7.80B8.56B9.57B9.52B10.16B
Gross Margin
40.08%39.25%37.89%39.77%38.96%38.94%
Operating Income
1.38B1.93B2.01B2.22B2.39B2.76B
Net Income
887.88M1.26B1.41B1.53B1.68B1.91B
EPS
----1.331.59
EPS Growth
----7.26%19.70%
Forward PE
34.5436.9025.1418.0414.1116.73
Dividend / Share
0.180.240.420.650.700.70
Dividend Growth
29.99%33.32%75.01%55.99%7.69%0.06%
Free Cash Flow
----3.06B3.07B
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High26.5B
Avg26.1B
Low25.6B

Revenue Growth

Revenue Growth202620272028
High
8.6%
Avg
6.7%
Low
4.8%

EPS Forecast

EPS202620272028
High1.63
Avg1.59
Low1.55

EPS Growth

EPS Growth202620272028
High
22.5%
Avg
19.7%
Low
16.8%